nih ghk-cu Order (100mg) Bloom Clinically Proven Copper GHK-CU

In vascular smooth muscle cells (VSMCs), it disrupts the TCA cycle and provokes ROS production, leading to cellular hypertrophy and phenotypic switching, which culminates in pathological thickening of the vascular wall [102]

Those are pharmacology results, not proof of a clinical benefit there is no controlled human trial showing CJC-1295 improves body composition, a disease outcome, or any functional measure, and the no-DAC form has no controlled human trials at all

Important Consultation Required As this is a prescription medicine, a medical consultation is mandatory before treatment can proceed

Sample 16-week strength protocol Weeks 1-16 (base): CJC-1295: 200mcg nightly Ipamorelin: 200mcg nightly BPC-157: 250mcg twice daily Weeks 1-6 (IGF-1 cycle): Add IGF-1 LR3: 60mcg post-workout Weeks 7-12 (off IGF-1): Continue base protocol only Weeks 13-16 (optional second IGF-1 cycle): Add IGF-1 LR3: 60mcg post-workout Expected outcome: 15-20 lbs muscle gain 25-40% strength increase in major lifts Minimal injuries Excellent body composition Use our peptide cycle planning guide for detailed cycle planning, peptide dosage chart for reference doses, and how to calculate peptide dosages for precision